Elismetrep

N/A

Report date: 2026/03/20 20:03:07
NME

Base Information

Drug NameElismetrep
Drug Alias NameMT-8554K-304
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransient receptor potential cation channel subfamily M member 8 antagonists
TargetsTransient receptor potential cation channel subfamily M member 8
Therapy Area/IndicationsDiabetic peripheral neuropathyVasomotor symptomHot Flashes +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandHungary +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Tanabe Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesMitsubishi Tanabe Pharma CorpKallyope Inc
Inactive CompaniesMitsubishi Tanabe Pharma America Inc
Active IndicationsDiabetic peripheral neuropathyMigraine Disorders
Inactive IndicationsVasomotor symptomHot Flashes

Other Information

ATC CodeN/A
Related LinksN/A